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Background: Childhood obesity is a nutrition‐related disease with multiple underly-
ing aetiologies. While genetic factors contribute to obesity, the gut microbiome is also
implicated through fermentation of nondigestible polysaccharides to short‐chain fatty
acids (SCFA), which provide some energy to the host and are postulated to act as sig-
nalling molecules to affect expression of gut hormones.
Objective: To study the cumulative association of causal, regulatory, and tagged
single nucleotide polymorphisms (SNPs) within genes involved in SCFA recognition
and metabolism with obesity.
Design: Study participants were non‐Hispanic White (NHW, n = 270) and non‐
Hispanic Black (NHB, n = 113) children (2‐5 years) from the Synergistic Theory and
Research on Obesity and Nutrition Group (STRONG) Kids 1 Study. SNP variables
were assigned values according to the additive, dominant, or recessive inheritance
models. Weighted genetic risk scores (GRS) were constructed by multiplying the
reassigned values by independently generated β‐coefficients or by summing the
β‐coefficients. Ethnicity‐specific SNPs were selected for inclusion in GRS by cohort.
Results: GRS were directly associated with body mass index (BMI) z‐score. The
models explained 3.75%, 12.9%, and 26.7% of the variance for NHW/NHB, NHW,
and NHB (β = 0.89 [CI: 0.43‐1.35], P = 0.0002; β = 0.78 [CI: 0.54‐1.03],
P < 0.0001; β = 0.74 [CI: 0.51–0.97], P < 0.0001).
Conclusion: This analysis supports the cumulative association of several candidate
genetic variants selected for their role in SCFA signalling, transport, and metabolism
with early‐onset obesity. These data strengthen the concept that microbiome influ-
ences obesity development through host genes interacting with SCFA.
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Childhood obesity is a nutrition‐related disease with multiple underly-
ing aetiologies. Genetics play a significant role in the development of
obesity, and twin studies indicate that the heritability of obesity
ranges from 40% to 70%.1 Meta‐regression analyses have provided
evidence that genetic influences on obesity are greater during child-
hood than in adulthood.2 Genome‐wide association studies (GWAS)
have revealed several hundred loci within the human genome associ-
ated with obesity in adults, although only eight independent loci have
been identified in children.3,4 Building upon GWAS findings, the
genetic risk score (GRS) approach has been employed to address
concerns in statistical analyses over multiple testing and to account
for the missing heritability of obesity.5 GRS constructed from
GWAS‐identified single nucleotide polymorphisms (SNPs) and tested
across prospective and retrospective cohorts support the notion that
the genetic effect on obesity‐related phenotypes is age‐dependent
with increasing influence peaking near the age of 20 (see
supplementing information for additional references).6-10 Cross‐
sectional studies in children also demonstrate a relationship between
GRS and measures of obesity (see supplementing information for addi-
tional references).11,12 However, the percent of variance of body mass
index (BMI) and other obesity‐related phenotypes explained by the
GRS in studies in children remains small ranging from 1.0% to 3.4%.
In fact, Le Chatelier suggested that the current obesity susceptibility
genetic variants identified from GWAS are less informative in
distinguishing between individuals who are lean and those who have
obesity than their microbiome within the gastrointestinal tract.13
One possible explanation of how the gut microbiome contributes
to obesity development includes the interaction between host genet-
ics and short‐chain fatty acids (SCFAs), the products of bacterial
fermentation of nondigestible polysaccharides.14 In particular,
butyrate promotes overall gut health while acetate and propionate
may increase host capacity for energy harvest and storage through
lipogenesis and gluconeogenesis.15,16 Through a review of the litera-
ture, we identified key genes involved in the transport and signalling
of SCFAs. From these genes, four main pathways were established:
(1) SCFA transport across the gut epithelium via monocarboxylate
transporter 1 (SLC16A1) and sodium‐coupled monocarboxylate trans-
porter 1 (SLC5A8) (apical membrane) and via monocarboxylate trans-
porters 4 and 5 (SLC16A3 and SLC16A4) (basolateral membrane.17,18
(2) SCFA signalling through free fatty acid receptors 2 and 3 (FFAR2
and 3) bind SCFAs and effect downstream regulation of appetite
through downstream effectors including peptide YY (PYY) and
glucagon‐like peptide 1 (GCG) in enteroendocrine L cells, and leptin
(LEP) in adipocytes.19,20 (3) Alterations in adipose storage through
angiopoietin‐like 4 (ANGPTL4), an inhibitor of lipoprotein lipase
(LPL).21 Both ANGPTL4 and LPL are under the transcriptional regula-
tion of peroxisome proliferator‐activated receptor gamma (PPARG).
(4) Immunological response to lipopolysaccharide (LPS) via toll‐like
receptor 4 (TLR4) and the inflammatory response by the expression
of nuclear factor kappa beta (NFKB) leading to the release of cytokines
interleukin 6 (IL6) and tumour necrosis factor alpha (TNFA).22SCFA receptors and transporters and other host responders to gut
microbiome have been described, but the collective impact of com-
mon functional and regulatory variants in these genes on obesity‐
related phenotypes has not been studied in humans. The current study
assessed the cumulative association of causal, regulatory, and tagged
SNP variants within genes involved in gut microbiome and/or SCFA
recognition and metabolism on obesity‐related phenotypes in
preschool‐age children. SNP‐SNP interactions within pathways were
also examined. We hypothesized that genetic variation in SCFA recog-
nition pathways would be positively associated with obesity‐related
phenotypes. GRS were constructed using both traditional (additive
model) and nontraditional (nonadditive models) methods taking into
consideration the magnitude and directionality of the effect size of
each SNP on the phenotype by weighting the score.2 | METHODS
2.1 | Study participants and anthropometric
measurements
Participants for this study were preschool age children (2‐5 years)
combined from the Synergistic Theory and Research on Obesity and
Nutrition Group (STRONG) Kids 1 Study (n = 475) cohorts from the
University of Illinois (Urbana, IL; n = 265) and the University of
Michigan (Ann Arbor, MI; n = 210).23 The study protocol received
approval from the Institutional Review Boards at both recruitment
sites. Data regarding age, sex and ethnicity were collected from a large
panel survey completed by study participant parents. Height and
weight were measured to calculate BMI and related measures using a
stadiometer (Peslter, USA) and electronic remote display scale (Jarden
Consumer Solutions, USA) with a precision level of 0.1 cm and 0.1 kg,
respectively. BMI, BMI percentile (BMIPCT), BMI z‐score for age
(BMIZ), weight for age z‐score (WAZ), and height for age z‐score
(HAZ) were calculated using the standard SAS program from the
Center for Disease Control and Prevention (CDC). Z‐scores express
the standard deviation from the mean to indicate a child's weight,
height, and BMI status according to the sex and age‐specific CDC
growth charts from 2000.24 Children with or without overweight were
defined as having a BMIPCT greater than or equal to 85th percentile or
BMIPCT less than 85th percentile, respectively. Children with BMIZ
above or below four standard deviations and those with known meta-
bolic disorders were excluded (n = 5). Only non‐Hispanic White (NHW)
and non‐Hispanic Black (NHB) study participants were included in the
following groups: NHW and NHB combined (NHW/NHB, n = 383),
NHW (n = 270), and NHB (n = 113).2.2 | Candidate gene and SNP selection
Candidate genes were identified after examination of the published
literature regarding each gene's known associations with gut
microbiome‐related molecules including SCFAs and LPS (FFAR2,
FFAR3, ANGPTL4, CD36, SLC16A1, SLC16A3, SLC16A4, SLC5A8, and
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the recognition of gut microbiome and SCFAs.14,25 Downstream
effector genes were also included to identify potential gene‐gene
interactions and to test the cumulative association of carrying risk
alleles in the development of obesity (LPL, PYY, GCG, LEP, LEPR, NPY,
NPY2R, PPARG, NFKB, IL6, and TNFA).20,22,26-33
The SNP selection was performed using a systematic approach.
SNPs within or near the genes of interest were selected for inclusion
primarily for their functional or regulatory potential. The Single Nucle-
otide Polymorphism Database (dbSNP) and Ensembl databases were
searched for SNPs located in high priority regions including the 5′
and 3′ untranslated regions (UTRs), exons (synonymous and non‐
synonymous variants), and the 10 base pair (bp) region within exon‐
intron boundaries.34 Several in silico tools were utilized to further
assess the likelihood that the SNP would impact protein function or
gene regulation. Less common variants (minor allele frequency
[MAF] < 10%) and, in particular, non‐synonymous SNPs were included
with consideration of their Sorting Tolerant from Intolerant (SIFT) and
PolyPhen scores.35,36 RegulomeDB and miRdSNP were used to
identify SNPs likely to affect transcription factor and microRNA bind-
ing respectively.37,38 In the SNP selection process, tag SNPs for the
genes of interest were also identified using Haploview version 4.2
(Cambridge, MA) when functional or regulatory SNPs were not avail-
able.39 Table S1 provides a summary of the 52 candidate SNPs.2.3 | DNA extraction and genotyping
Genomic DNA (gDNA) was extracted and purified following the
Oragene‐DNA protocol for the manual purification of DNA from saliva
(average yield = 9.8 μg, average OD 260/280 ratio = 1.9). Selected
markers (52 total SNPs) were genotyped using either the Fluidigm
SNP genotyping platform or TaqMan genotyping assays. For the
Fluidigm protocol, the assay design was constructed on the Fluidigm
D3 website. The Functional Genomic Unit of the W.M. Keck Center
at the University of Illinois performed preamplification and genotyping
using 250 ng of gDNA. Genotypes were called using Fluidigm
Genotyping Analysis version 4.1.2 (San Francisco, CA, USA) at a
minimum of 85% reliability. The TaqMan procedure was performed
in the 7900 Real‐Time machine using assays predesigned for
FFAR1‐rs10423648 and FFAR1‐rs10422744 and a custom assay for
FFAR3‐rs424241. Fluorescent signals were detected for VIC and
FAM after PCR, and genotypes were assigned using the allelic discrim-
ination program in the sequence detection systems (SDS) 2.4 software
(Applied Biosystems, Carlsbad, CA, USA).2.4 | Statistical analysis
The MAFs, linkage disequilibrium (LD), and Hardy–Weinberg equilib-
rium (HWE) were calculated using the SNP & Variation Suite (SVS)
software version 8 (Golden Helix, Bozeman, MT). MAFs were calcu-
lated for NHW/NHB, NHW, and NHB. D' and r2 statistics were com-
puted for SNPs located within the same chromosome for the NHWand NHB cohorts respectively using the composite haplotype method
(CHM) in SVS. For genomic regions with multiple SNPs of interest in
LD, the SNP with the strongest association with the phenotype was
kept for GRS construction. χ2 tests were used in the NHW and NHB
cohorts to identify significant departures from HWE. SNPs were
excluded from the analyses if the genotype call rate was less than
95%, HWE P value was less than 0.05, or the MAF was less than
0.05. The total number of SNPs analysed for each cohort were as
follows: 15 SNPs in NHW/NHB, 47 SNPs in NHW, and 38 SNPs in
NHB. SNPs were further selected for the GRS based on a P value < 0.3
for the association with BMIZ using the general linear model select
(GLMSELECT) procedure. Although less conservative, this threshold
allows for the potential for SNP combinations to have synergistic
effects within the GRS. Eight total models were used where SNPs
were grouped by pathway, and dominant and recessive models were
tested. GRS were constructed for the NHW/NHB, NHW, and NHB
using ethnicity‐specific SNPs for the outcome, BMIZ, with 5, 10, and
9 SNPs selected for each cohort respectively. SNPs included for GRS
in NHW/NHB cohort had similar MAF (Table S1).
A total of five GRS were constructed for each cohort: additive
nonweighted (GRS‐add‐NW), nontraditional nonweighted (GRS‐non‐
NW), additive weighted (GRS‐add‐W), nontraditional weighted (GRS‐
non‐W), and genotypic weighted (GRS‐gen‐W). To construct the
GRS‐add‐NW, each genotype group for the selected SNPs was
assigned the value 0, 1, or 2 according to the additive model of risk
and the values were summed. Construction of the GRS‐non‐NW
was performed by reassigning the genotype groups as 0 or 1 according
to the dominant or recessive models of risk and then summing the
values. β‐coefficients for each SNP were estimated in the general
linear model (GLM) and were used to obtain the three weighted risk
scores. Assigned values for the GRS‐add‐NW were multiplied by their
β‐coefficients and summed to generate the GRS‐add‐W. For the GRS‐
non‐W, assigned values from the GRS‐non‐NW were multiplied by
their β‐coefficients and summed. The GRS‐gen‐W was constructed
without assumption of genetic model; β‐coefficients were summed
without multiplication of an assigned value (the referent genotype
group assigned a value of “0”). The Cochran‐Armitage exact test was
conducted to predict the goodness of fit to the additive model of
inheritance. The β‐coefficients used for the weighted scores and the
P values for the Cochran‐Armitage exact test are shown in Table S2.
Normality for the GRS variables was assessed by examining skewness
and kurtosis. The skewness values were greater than −1 and the
kurtosis values were less than 1 for all constructed GRS.
The associations between the BMIZ outcome and each of the five
types of GRS were assessed using linear regression. Logistic regression
was used to generate receiver operating characteristic (ROC) curves to
assess the specificity and sensitivity of each GRS to examine accuracy
of each type of GRS in discriminating children with or without over-
weight within each cohort. Each GRS developed for BMIZ was applied
to WAZ and HAZ. Gene‐gene interactions were evaluated in each
pathway by using SNP‐SNP interaction terms in the GLM. All statisti-
cal analyses were performed with age and sex as covariates using SAS
9.4 (SAS Institute Inc., Cary, NC). An additional covariate for age (age2)
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with the phenotype. P values were considered significant after
modification according to Bonferroni correction by dividing 0.05 by
the number of pathways tested (4), the number of SNPs included in
each respective cohort's GRS (5, 10, and 9), and the number of GRS
(5) (NHW/NHB P < 0.0005, NHW P < 0.00025, NHB P < 0.00028).
Bonferroni correction was also used for SNP‐SNP interaction
analyses, and those P values are provided in Figure S2. Bootstrapping
analyses were conducted at 10, 100, 500, and 1000 replications to
re‐evaluate the observed associations between the constructed GRS
and BMIZ.
Ancestry informative markers (AIMs, n = 64) were obtained from
a previous report and used to generate continuous admixture scores
to account for ethnicity within the combined NHW/NHB cohort
(Table S3).40 Admixture scores were generated using principal com-
ponent analysis in SVS with the first three principal component
scores for the 64 AIMs included as covariates. Eigenvalues for the
principal components generated were 60.2, 10.4, and 10.1.3 | RESULTS
3.1 | Participant demographics and descriptive data
for genetic markers
Descriptive data of the STRONG Kids 1 study is presented in Table 1.
The prevalence of children with normal weight, overweight, or obesity
in the NHW/NHB cohort was 78.9%, 14.6%, and 6.5%, respectively.
No significant differences in age, height, BMI, or z‐scores were found
between boys and girls. There were no differences in any of the
anthropometric measurements or rates of overweight and obesity
amongst the NHW and NHB cohorts. MAFs and HWE values for each
SNP and LD tables by cohort for the genes of interest are summarized
in Tables S1 and S4, respectively.TABLE 1 Descriptive characteristics of children in the STRONG Kids coh
Variable NHW/NHB n = 384 Male n = 188 Female n = 19
Age, months 47.8 ± 10.6 47.0 ± 10.2 48.6 ± 10.9
Height, cm 102.5 ± 7.6 102.5 ± 7.3 102.5 ± 8.0
Weight, kg 17.0 ± 3.0 17.1 ± 2.5 17.0 ± 3.3
BMI, kg/m2 16.1 ± 1.4 16.2 ± 1.2 16.0 ± 1.6
BMIPCT, % 59.4 ± 27.1 59.7 ± 26.5 59.0 ± 27.7
BMIZ 0.30 ± 0.95 0.32 ± 0.89 0.29 ± 1.00
HAZ 0.28 ± 1.04 0.25 ± 1.10 0.30 ± 0.98
WAZ 0.33 ± 0.99 0.38 ± 1.02 0.28 ± 0.95
Overweight, % 14.6 17.0 12.2
Obese, % 6.5 4.8 8.2
Abbreviations: BMI, body mass index; BMIPCT, BMI percentile; BMIZ, BMI z‐s
Hispanic White; WAZ, Weight‐for‐age z‐score. N = 384, 188 males (49%), 1
variables were generated using Student's t test for continuous variables and3.2 | Genetic risk scores
The SNPs selected for the construction of the GRS for each cohort and
the rationale for their inclusion are in Table 2. As described earlier, all
SNPs included in the GRS demonstrated a direct relationship with
BMIZ according to the genetic modes of inheritance listed. Apart from
the GRS‐add‐W in NHW/NHB, all GRS were associated with BMIZ. R2
values and percent of BMIZ variance explained (BMIZ%) increased as
the GRS progressed from additive to nonadditive and from
nonweighted to weighted approaches in all three cohorts. GRS‐non‐
W and GRS‐gen‐W explained the largest BMIZ% and had the highest
R2 values across and within the cohorts. GRS‐gen‐W explained 3.8%,
12.9%, and 26.7% of the variance in BMIZ in the NHW/NHB, NHW,
and NHB cohorts respectively. A summary of the five GRS constructed
is provided in Table 3 including β‐coefficients and 95% CIs, and com-
parisons of the nonweighted and weighted scores for NHW and
NHB are shown in Figures 1 and 2. Bootstrapping at 10, 100, and
1000 replications of the data set confirmed the associations between
the GRS and BMIZ (Table 4). All significant GRS remained significant
after Bonferroni correction except GRS‐add‐NW in NHH/NHB.
In general, analysis using logistic regression demonstrated similar
results as observed when using linear regression. However, only the
area under the curve (AUC) values for NHW improved when
progressing from additive to nonadditive and from nonweighted to
weighted approaches (AUC range: 0.57‐0.64). The AUC values for
the GRS in NHW/NHB and NHB remained relatively the same across
GRS regardless of risk score construction method (Table 3 and Figure
S1). While the AUC values in the NHB GRS were the highest (AUC
range: 0.72‐0.78), the NHW/NHB GRS performed the poorest in
predicting children with overweight (AUC range 0.55‐0.57). The
NHW/NHB GRS had the lowest BMIZ% and further analysis into
the strength of association of the GRS within NHW and NHB sepa-
rately revealed a differential relationship. Whereas the GRS for
NHW/NHB was associated with BMIZ in NHW, these GRS were not
associated with BMIZ in NHB (data not shown).ort stratified by sex and ethnicity
6 P value NHW only n = 270 NHB only n = 114 P value
0.13 47.8 ± 10.7 47.9 ± 10.2 0.93
0.99 102.2 ± 7.7 103.1 ± 7.4 0.27
0.66 17.0 ± 2.9 17.2 ± 3.1 0.54
0.21 16.2 ± 1.4 16.1 ± 1.6 0.56
0.80 60.6 ± 27.9 56.5 ± 27.5 0.19
0.75 0.34 ± 0.93 0.22 ± 0.97 0.27
0.66 0.22 ± 0.93 0.41 ± 1.26 0.14
0.34 0.32 ± 0.90 0.37 ± 1.16 0.65
0.30 22.2 18.4 0.41
0.19 6.1 6.7 0.81
core; HAZ, height‐for‐age z‐score; NHB, non‐Hispanic Black; NHW, non‐
96 females. Data are presented as means ± SD. P values for continuous
chi‐square for categorical variables.
TABLE 2 SNP inclusion in GRS for BMIZ by cohort
Gene SNP Risk Allele Mode of Inheritance P value Function
NHW/NHB
PPARG rs12639162 A Dominant 0.0554 Intron variant, tagged SNP
ANGPTL4 rs1044250 C Recessive 0.1859 Missense variant
IL6 rs1554606 T Dominant 0.0139 Intron variant, tagged SNP
SLC16A3 rs3176827 T Dominant 0.0723 Intron variant, possible splice variant
PYY rs2070592 G Recessive 0.2038 5’ UTR variant, possible splice variant
NHW only
PPARG rs12639162 A Dominant 0.0103 Intron variant, tagged SNP
ANGPTL4 rs1044250 C Recessive 0.2030 Missense variant
ANGPTL3 rs10889337 G Dominant 0.0459 Intron variant
LPL rs13702 A Recessive 0.0031 3’ UTR variant
PYY rs2014257 A Dominant 0.1013 TF binding motif
NPY2R rs1047214 C Recessive 0.2346 Synonymous variant
SLC5A8 rs7309172 G Dominant 0.0916 3’ UTR variant
SLC16A3 rs3176827 T Dominant 0.1303 Intron variant, possible splice variant
SLC16A1 rs9429505 G Dominant 0.0691 3’ UTR variant, tagged SNP
IL6 rs1554606 T Dominant 0.1087 Intron variant, tagged SNP
NHB only
CD36 rs3173798 C Dominant 0.0676 Possible splice variant
PYY rs2070592 G Recessive 0.0909 5’ UTR variant, possible splice variant
NPY2R rs2880415 A Dominant 0.0181 Synonymous variant
LEP rs11761556 C Dominant 0.2450 Upstream variant, TF binding motif
SLC16A4 rs12062656 G Dominant 0.0436 Intron variant, tagged SNP
SLC16A3 rs4789698 G Recessive 0.0328 Downstream variant, tagged SNP
SLC5A8 rs1709189 C Dominant 0.0898 Missense variant
TLR4 rs4986790 A Dominant 0.1146 Missense variant
IL6 rs1554606 T Dominant 0.0275 Intron variant, tagged SNP
Abbreviations: ANGPTL3, angiopoietin‐like 3; ANGPTL4, angiopoietin‐like 4; BMIZ, BMI z‐score; CD36, cluster of differentiation 36; GRS, genetic risk score;
IL6, interleukin 6; LPL, lipoprotein lipase; NHB, non‐Hispanic Black; NHW, non‐Hispanic White; NPY2R, neuropeptide Y receptor Y2; PPARG, peroxisome
proliferator‐activated receptor gamma; PYY, peptide YY; SLC5A8, solute carrier family 5 member 8; SLC16A3, solute carrier family 16 member 3; SLC16A1,
solute carrier family 16 member 1; SNP, single nucleotide polymorphism; TLR4, toll‐like receptor 4; TF, transcription factor; UTR, untranslated region.
Determination of SNPs to be included in GRS for NHW/NHB was based on strength of association with BMIZ using general linear model (GLM). SNP inclu-
sion for NHW and NHB GRS were based on GLMSELECT procedure of SNPs by pathway using both the dominant and recessive modes of inheritance
(eight total models). Set limit entry (SLE) and set limit stay (SLS) were set to 0.3. A total of five, 10, and nine SNPs were selected for the NHW/NHB,
NHW, and NHB cohorts respectively.
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ing more to the GRS than others by constructing scores by pathway
within the NHW and NHB cohorts. In the NHW GRS‐gen‐W, we
observed that SNPs representing genes in the adipose storage path-
way (ANGPTL4‐rs1044250, LPL‐rs13702, and PPARG‐rs12639162)
contributed to nearly half of the BMIZ% (R2 = 0.07, 6.44%). For
NHB, both the transport and signalling pathways contributed approx-
imately equal amounts to the GRS‐gen‐W (R2 = 0.1050, 12.21% and
R2 = 0.0982, 11.27%, respectively). Although the majority of the SNPs
in the GRS for NHW and NHB were different, each shared IL6‐
rs1554606 and many of the same genes (PYY, SLC5A8, and NPY2R).
GRS‐non‐W and GRS‐gen‐W for BMIZ were also applied to WAZand HAZ in all three cohorts (Table S5). Although the percent of vari-
ance explained was reduced, the GRS for BMIZ were associated with
WAZ. The GRS for BMIZ, however; were not associated with HAZ.3.3 | Gene–gene interactions
The SNP‐SNP model and interaction term P values for BMIZ by
pathway and by cohort (NHW and NHB separately) are shown in
Figure S2. Two interactions were initially observed in NHW:
ANGPTL4‐rs1044250 and LPL‐rs13702 (P = 0.0032) and ANGPTL3‐
rs10889337 and PPARG‐rs12639162 (P = 0.0222). SNPs representing
TABLE 3 Comparison of GRS by cohort for BMIZ using linear and logistic** regression
GRS‐add‐NW GRS‐add‐W GRS‐non‐NW GRS‐non‐W GRS‐gen‐W
NHW/NHB
Adj R2 0.0265 0.0179 0.0388 0.0397 0.0404
BMIZ% variance explained 2.38 1.54 3.59 3.68 3.75
Model P value 0.0183 0.0578 0.0030 0.0026 0.0024
GRS P value 0.0027 0.0160 0.0002 0.0002 0.0002
β‐coefficient, 95% CI 0.10 (0.04‐0.17) 0.51 (0.10‐0.92) 0.19 (0.090‐0.29) 0.92 (0.44‐1.41) 0.89 (0.43‐1.35)
AUC, CI** 0.57 (0.50‐0.64) 0.55 (0.48‐0.62) 0.57 (0.51‐0.64) 0.57 (0.50‐0.65) 0.57 (0.50‐0.65)
OR, CI** 1.24 (1.03‐1.48) 1.99 (0.67‐5.87) 1.41 (1.07‐1.85) 4.93 (1.30‐18.67) 4.36 (1.24‐15.39)
NHW only
Adj R2 0.0220 0.0657 0.0983 0.1242 0.1277
BMIZ% variance explained 2.45 6.77 10.00 12.55 12.90
Model P value 0.0319 <0.0001 <0.0001 <0.0001 <0.0001
GRS P value 0.0106 <0.0001 <0.0001 <0.0001 <0.0001
β‐coefficient, 95% CI 0.07 (0.02‐0.12) 0.32 (0.18‐0.47) 0.20 (0.13‐0.27) 0.84 (0.57‐1.10) 0.78 (0.54‐1.03)
AUC, CI** 0.57 (0.49‐0.65) 0.60 (0.53‐0.68) 0.63 (0.56‐0.70) 0.64 (0.56‐0.72) 0.64 (0.56‐0.72)
OR, CI** 1.16 (1.00‐1.35) 1.74 (1.12‐2.69) 1.40 (1.12‐1.74) 3.95 (1.62‐9.61) 3.69 (1.62‐8.42)
NHB only
Adj R2 0.0987 0.1532 0.2278 0.2322 0.2567
BMIZ% variance explained 11.32 16.47 23.90 24.33 26.69
Model P value 0.0025 <0.0001 <0.0001 <0.0001 <0.0001
GRS P value 0.0003 <0.0001 <0.0001 <0.0001 <0.0001
β‐coefficient, 95% CI 0.18 (0.09‐0.28) 0.44 (0.25‐0.63) 0.29 (0.19‐0.38) 0.76 (0.50‐1.01) 0.74 (0.51‐0.97)
AUC, CI** 0.77 (0.64‐0.90) 0.72 (0.62‐0.82) 0.76 (0.64‐0.88) 0.74 (0.62‐0.87) 0.78 (0.68‐0.88)
OR, CI** 1.87 (1.32‐2.65) 2.78 (1.40‐5.55) 2.11 (1.43‐3.12) 5.90 (2.21‐15.70) 5.76 (2.23‐14.87)
Abbreviations: Adj R2, adjusted R2; AUC, area under curve; BMIZ, BMI z‐score; BMIZ%, percent of BMIZ variance explained; CI, confidence interval; GRS,
genetic risk score; GRS‐add‐NW, additive nonweighted; GRS‐non‐NW, nontraditional nonweighted; GRS‐add‐W, additive weighted; GRS‐non‐W, nontra-
ditional weighted; GRS‐gen‐W, genotypic weighted; NHB, non‐Hispanic Black; NHW, non‐Hispanic White; OR, odds ratio. The five GRS constructed for
each cohort were compared. Adj R2, BMIZ% variance explained, β‐coefficients with 95% CI, model P value, and GRS P value were obtained using linear
regression. AUC and ORs were obtained using logistic regression to compare children with or without overweight and are denoted with **. Age and sex
were included in the statistical models as covariates. Three principal component scores derived from principal component analysis of 64 ancestry informa-
tive markers were included as covariates for the NHW/NHB cohort. All GRS were associated with BMIZ (P value < 0.05) with the exception of GRS‐add‐W
in NHW/NHB (P = 0.0578). Adj R2, BMIZ%, and GRS P value improved from GRS‐add‐NW to GRS‐gen‐W across all cohorts. The BMIZ% was highest for
GRS‐gen‐W (3.8%, 12.9%, and 26.7%) for the NHW/NHB, NHW, and NHB cohorts, respectively.
6 of 12 WANG ET AL.FFAR1‐3 appeared to interact with several SNPs for PYY, GHRL, LEP,
NPY2R, and NPY in pathway 2 (SCFA signalling through free fatty acid
receptors) for both the NHW and NHB cohorts, although the model P
values did not reach statistical significance initially. In NHB, an
interaction between FFAR3‐rs424241 and NPY2R‐rs1047214 was
observed (P = 0.0014). None of the interactions observed remained
significant after multiple testing correction. There were no other
appreciable differences when comparing the SNP‐SNP interactions
between the NHW and NHB cohorts.4 | DISCUSSION
The current study sought to describe the cumulative relationship
between several SCFAs and LPS associated genes and obesityphenotypes in children. These results provide an example of the poten-
tial benefits of an integrative approach. Rather than selecting SNPs from
GWAS, we utilized traditional and nontraditional methods of genetic
analyses with a selection procedure of genetic variants rooted in the
biological mechanisms underlying obesity. Specifically, we constructed
genetic scores consisting of functional, regulatory, and tag SNPs in
genes with known and proposed interactions with the gut microbiome.
The GRS consisting of variants with putative roles in SCFA recognition
and transport demonstrated significant relationships with BMIZ and
WAZ in NHW and NHB children when analysed both separately and
together. This approach not only provides an avenue to better under-
stand the mechanisms driving obesity development early in life but also
may identify potential targets for intervention strategies in the future.
Another advantage of the pathway‐based approach is the ability to
investigate gene‐gene interactions. Most notably, we showed a
FIGURE 1 Histograms (panels A‐D) in Figure 1 represent the distribution of risk alleles for the GRS‐add‐NW and GRS‐non‐NW in the NHW
(n = 270) and NHB (n = 113) cohorts. Ten SNPs for the NHW GRS and nine SNPs for the NHB GRS were selected based on their independent
association with BMIZ using the GLM select procedure. To construct the GRS‐add‐NW, genotype groups for the selected SNPs were assigned 0, 1,
or 2 according to the additive model of risk and the values were summed. To construct the GRS‐non‐NW, genotype groups were reassigned 0 or 1
according to the dominant or recessive models of risk and the values were summed. GRS for NHW are shown in panels A and B while GRS for NHB
are shown in panels C and D. All X‐axes represent risk allele group categories for the GRS‐add‐NW (panels A and C) and GRS‐non‐NW (panels B
and D). The left Y‐axes represent the BMIPCT, and the right Y‐axes represent the number of individuals in each risk allele group. Data points on the
line plots imposed over the histograms represent the mean BMIPCT for individuals in each risk allele group. The dashed lines are linear regression
curves. Low, medium, and high genetic risk categories were assigned for each GRS. NHW children in the low‐risk category (n = 40, less than or
equal to seven risk alleles) for GRS‐add‐NW had lower BMIZ than those in the high‐risk category (n = 42, greater than or equal to 14 risk alleles
(0.10 ± 0.14 vs 0.54 ± 0.14, P = 0.0256) (panel A). NHW children in the medium‐risk category (n = 183, 10‐13 risk alleles) did not differ in BMIZ
from either the low‐risk or high‐risk groups. NHB children in the low‐risk category (n = 15, less than or equal to seven risk alleles) and medium‐risk
category (n = 74, 8‐10 risk alleles) for GRS‐add‐NW had lower BMIZ than those in the high‐risk category (n = 24, greater than or equal to 11 risk
alleles) (−0.31 ± 0.23 and 0.08 ± 0.10 vs 0.95 ± 0.18, P < 0.0001) (panel C). Abbreviations: BMIPCT, BMI percentile; BMIZ, BMI z‐score; GLM,
general linear model; GRS, genetic risk score; GRS‐add‐NW, additive nonweighted GRS; GRS‐non‐NW, nontraditional nonweighted GRS; NHB,
non‐Hispanic Black; NHW, non‐Hispanic White
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in NHW, which is consistent with the known role of ANGPTL4 as an
inhibitor of LPL activity.21 Although the interactions did not survive
rigorous multiple testing correction, Figure S2 illustrates potential
SNP‐SNP relationships that could be further explored provided an
adequate sample size to conduct multiple testing. The SNP‐SNP
interactions examined in the present study were limited to the four
selected pathways. Future studies should continue to search for
functional variants and to test for genetic interactions as more
evidence of these relationships becomes available. Regarding the
genetic architecture of complex diseases such as obesity, additive
contributions of genetic variants that are independent of each other
have traditionally been assumed. However, Zuk et al suggested that
this approach may generate phantom heritability as gene‐gene and
gene‐environment interactions are not taken into consideration andestimated heritability of a phenotype may be inflated.41 In fact, new
approaches include statistical models that attempt to account for the
impact of gene‐environment interactions.42
The variance of the phenotype explained in genetic studies has been
limited. Two statistical approaches in the current study strengthen the
ability to describe the variance in the phenotype attributed to the
GRS. First, application of β‐coefficients to estimate the effect size of
each SNPs' contribution to the phenotype improved the percent of var-
iance explained by the GRS, which was anticipated based on simulation
data.43 Past studies have favoured the use of weighted values obtained
from previously analysed GWAS data sets to remove bias within the
sample set of interest.9,44-46 We recognize that our use of weighted
values derived from our own cohort could contribute to model
overfitting; however, the use of weighted values from adult data sets
may not be appropriate for child cohorts as genetic contributions to
FIGURE 2 Linear regression curves for the GRS‐add‐W, GRS‐non‐W, and GRS‐gen‐W are displayed in panels A to F of Figure 2 for the NHW
(n = 270) and NHB (n = 113) cohorts. Ten SNPs for the NHW GRS and nine SNPs for the NHB GRS were selected based on their independent
associationwith BMIZ using theGLM select procedure. To construct theGRS‐add‐W, genotype groups for the selected SNPswere assigned 0, 1, or 2
according to the additive model of risk, multiplied by their respective β‐coefficient, and the values were summed. To construct the GRS‐non‐W,
genotype groups were reassigned 0 or 1 according to the dominant or recessive models of risk, multiplied by their respective β‐coefficients, and the
values were summed. To construct the GRS‐gen‐W, β‐coefficients were summed for each selected SNP. GRS for NHW are shown in panels A to C
while GRS for NHB are shown in panels D to F. All X‐axes represent the composite GRS, while all Y‐axes represent BMIZ. Adj R2 and percent of
variance explained for BMIZ increases across panels A to C for NHW and across panels D to F for NHB. GRS‐gen‐W had the highest percent of
variance explained for BMIZ for both NHWand NHB cohorts. Abbreviations: Adj R2, adjusted R2; BMIPCT, BMI percentile; BMIZ, BMI z‐score; GRS,
genetic risk score; GRS‐add‐W, additive weighted GRS; GRS‐non‐W, nontraditional weighted GRS; GRS‐gen‐W, genotypic GRS; NHB, non‐Hispanic
Black; NHW, non‐Hispanic White
8 of 12 WANG ET AL.obesity are known to be age‐dependent.2,47 Longitudinal assessments
of the GRS are particularly needed at critical phases of development,
including infant peak, adiposity rebound, and puberty. Second,
comparison of the GRS‐add‐W to the GRS‐gen‐W suggests that a
hypothesis‐free approach to the genetic mode of inheritance is more
representative of the genotype‐phenotype relationship than assuming
the inheritance model. Traditional methods of constructing GRS apply
the additive mode of inheritance with the advantage being an improve-
ment in the power of the analysis.48 However, the genetic model is
seldom known a priori and conforming SNPs to thesemodels in our data
set presented concerns in calculating the GRS. New statistical methods
including the MAX and MERT methods have been developed to better
predict the mode of inheritance from the empirical data and could be
used in follow‐up analyses of the GRS herein.49
Data using the GRS approach in a multi‐ethnic cohort of children
are limited. The Klimentidis study was the first to show that the meanGRS value for GWAS obesity variants was different amongst African
American, Hispanic, European American, and biracial groups.50 Simi-
larly, we found that the NHW/NHB GRS was associated with BMIZ
in NHW (n = 270) but not in NHB (n = 113). There is a possibility that
certain pathways may be contributing more to the GRS than other
pathways within the NHW and NHB cohorts. While SNPs in the
adipose storage pathway were well represented in the NHW GRS,
the NHB GRS appeared to be represented equally by both transport
and signalling pathway SNPs. The underlying mechanisms driving
excess adipose accumulation may be different amongst NHW and
NHB children. Our data further demonstrated that similar genes were
associated with obesity‐related phenotypes in the NHW and NHB
cohorts, but the SNPs carrying those signals often differed between
the groups. This presents a challenge for researchers to find and
establish shared genetic variants that can be used for association stud-
ies in multi‐ethnic cohorts. We conducted PCA of AIMs to account for
TABLE 4 Comparison of GRS after bootstrapping with 10, 100, and 1000 replications
10 replications 100 replications 1000 replications
GRS‐non‐W GRS‐gen‐W GRS‐non‐W GRS‐gen‐W GRS‐non‐W GRS‐gen‐W
NHW/NHB
Adjusted R2 0.0589 0.0564 0.0572 0.0573 0.0577 0.0582
BMIZ% variance explained 4.15 3.90 3.59 3.60 3.72 3.77
Model P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
















Adjusted R2 0.1437 0.1462 0.1341 0.1362 0.1334 0.1376
BMIZ% variance explained 13.40 13.65 12.69 12.90 12.52 12.94
Model P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
GRS P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001













Adjusted R2 0.2372 0.2748 0.2392 0.2686 0.2543 0.2772
BMIZ% variance explained 21.55 25.28 23.18 26.11 24.43 26.72
Model P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
GRS P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001












Abbreviations: BMIZ, BMI z‐score; BMIZ%, percent of BMIZ variance explained; GRS, genetic risk score; GRS‐non‐W, nontraditional weighted; GRS‐gen‐W,
genotypic weighted; NHB, non‐Hispanic Black; NHW, non‐Hispanic White. Adjusted R2, % BMIZ variance explained, β‐coefficients with 95% CI, Model P
value, and GRS P value were obtained using linear regression at 10, 100, and 1000 replications of the data set.
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this method was the creation of several continuous variables that
could more accurately characterize differences amongst and within
ethnic groups than a single categorical variable. Use of this technique
could be valuable in future work in the field of genetic epidemiology
as admixed populations increase the likelihood of false positive discov-
ery if population stratification is not taken into consideration.53,54
We recognize several limitations to the findings presented in this
report. Because the sample size was limited, our results need to be
replicated and the statistical methods employed should be cross‐
validated in an independent data set. Several of the genes selected
for this study including SLC16A1 and FFAR3 have expression in tissue
beyond the gastrointestinal tract.55-57 While the premise of this work
was based on the transport and signalling pathways of SCFAs pro-
duced by gut microbes in the distal intestinal tract, the relationship
between the GRS described here and obesity‐related phenotypes
may not be exclusively through the proposed pathways. The exact
effect of host genetic variation in SCFA‐associated genes coding for
the solute carriers and free fatty acid receptors on SCFA uptake and
recognition also has not been fully elucidated. Nevertheless, the stage
has been set to further elucidate the underlying genetic and microbial
mechanisms of obesity development in children. In fact, our approach
is complementary to a recent review published by Dong andcolleagues, which investigated the functional consequences of
obesity‐susceptibility loci and SNPs' identified by GWAS.58
In summary, the analytical methodology introduced in this study
contributes to establishing a novel way by which basic research in
molecular and genetic mechanisms of obesity can be utilized in
population‐level genetic analyses. Past works have shown relation-
ships between many of the same genes and other disease‐related phe-
notypes including biomarkers of cardiovascular and metabolic disease,
but this is the first report to our knowledge that combined their
effects into an obesity risk score in children (see supplementing infor-
mation for references). While the pathway‐based approach provided a
biological basis for SNP selection, the statistical methods used here
improved our ability to describe the genotype‐phenotype relationship.
Some GRS studies in infants and children have utilized the weighted
score approach, but the hypothesis‐free approach to the mode of
inheritance for each SNP represents a departure from the traditional
methods of producing GRS.ACKNOWLEDGEMENTS
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